173
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Molecular heterogeneity and centrosome-associated genes in multiple myeloma

, , , , , , , , & show all
Pages 1982-1988 | Received 26 Jul 2012, Accepted 02 Jan 2013, Published online: 18 Feb 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Annette E. Hay, Alli Murugesan, Ashley M. DiPasquale, Tom Kouroukis, Irwindeep Sandhu, Vishal Kukreti, Nizar J. Bahlis, Johan Lategan, Donna E. Reece, John F. Lyons, Joana Sederias, Hao Xu, Jean Powers, Lesley K. Seymour & Tony Reiman. (2016) A phase II study of AT9283, an aurora kinase inhibitor, in patients with relapsed or refractory multiple myeloma: NCIC clinical trials group IND.191. Leukemia & Lymphoma 57:6, pages 1463-1466.
Read now

Articles from other publishers (4)

Fedor Kryukov, Pavel Nemec, Lenka Radova, Elena Kryukova, Samuel Okubote, Jiri Minarik, Zdena Stefanikova, Ludek Pour & Roman Hajek. (2016) Centrosome associated genes pattern for risk sub-stratification in multiple myeloma. Journal of Translational Medicine 14:1.
Crossref
Daniele Tibullo, Nunzia Caporarello, Cesarina Giallongo, Carmelina Anfuso, Claudia Genovese, Carmen Arlotta, Fabrizio Puglisi, Nunziatina Parrinello, Vincenzo Bramanti, Alessandra Romano, Gabriella Lupo, Valeria Toscano, Roberto Avola, Maria Brundo, Francesco Di Raimondo & Salvatore Raccuia. (2016) Antiproliferative and Antiangiogenic Effects of Punica granatum Juice (PGJ) in Multiple Myeloma (MM). Nutrients 8:10, pages 611.
Crossref
N. E. U. Hermansen, R. Borup, M. K. Andersen, A. J. Vangsted, N. T. Clausen, D. L. Kristensen, F. C. Nielsen & P. Gimsing. (2016) Gene expression risk signatures maintain prognostic power in multiple myeloma despite microarray probe set translation. International Journal of Laboratory Hematology 38:3, pages 298-307.
Crossref
Elena Kryukova, Fedor Kryukov & Roman Hajek. (2016) Centrosome amplification and clonal evolution in multiple myeloma: Short review. Critical Reviews in Oncology/Hematology 98, pages 116-121.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.